Abstract
The pharmacokinetics of doxepin (DX) was studied in 21 Saudi patients treated long term with oral doses of this tricyclic antidepressant agent. The mean (SEM) values of the dose-normalized steady-state concentration and the apparent clearance after oral administration of this drug were 25.8 (4.8) ng·ml-1/mg·kg-1 and 2.529 (0.342) l·h-1·kg-1, respectively. The pharmacokinetics of impramine (IMI) was also studied in 30 Saudi patients who received oral doses of this drug for long durations. The mean dose-normalized steady-state concentration of IMI was 68.3 (19.7) ng·ml-1/mg·kg-1, and the mean apparent clearance after oral administration of IMI was 1.619 (0.353) l·h-1·kg-1. The mean (SEM) ratio of the steady-state concentration of the metabolite desipramine (DES) to that of IMI (DES/IMI) was 0.873 (0.151). Using this value and the ratio of the mean apparent clearance after oral administration (TCL) of DES to that of IMI, the fraction of IMI metabolized to DES was calculated to be 0.489. The TCL of DES was estimated from data obtained for three additional patients who received oral doses of this drug for long durations. A mean value of 0.907 (0.351) l·h-1·kg-1 was obtained.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abernathy DR, Greenblatt DJ, Shader RI (1984) Imipramine disposition in users of oral contraceptive steroids. Clin Pharmacol Ther 35:792–797
Alexanderson B (1972) Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses. Eur J Clin Pharmacol 5:1–10
Alexanderson B, Evans DA, Sjoqvist F (1969) Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J 4:744–768
Allen JJ, Rack PH, Vaddadi KS (1977) Differences in effects of clomipramine on English and Asian volunteers. Preliminary report on a pilot study. Postgrad Med J [Suppl 4] 53:79–86
Biggs JT, Preskorn SH, Ziegler VE, Rosen SH, Meyer DA (1978) Dosage schedule and plasma levels of doxepin and desmethyl-doxepin. J Clin Psychiatry 39:740–742
Bogaert MG, Rosseel MT, Deberdt R, Vranckx C (1981) Plasma levels of the cis- and trans-isomers of doxepin and desmethyldoxepin after administration of doxepin to patients. Drug Res 31 (I):113–115
Brosen K, Gram LF, Klysner R, Beth P (1986) Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics. Eur J Clin Pharmacol 30:43–49
Clark DWJ (1985) Genetically determined variability in acetylation and oxidation Therapeutic implications. Drugs 29:342–375
DeVane CL, Jusko WJ (1981) Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine. Drug Intell Clin Pharm 15:263–266
Dobbs JH (1983) The tricyclic antidepressants. In: Mungall DR (ed) Applied clinical pharmacokinetics. Raven Press, New York, pp 271–284
El-Yazigi A, Chaleby K (1987) Steady-state concentrations of amitriptyline and its metabolite nortriptyline in Saudi patients. Ther Drug Monit 9:6–10
Faulkner RD, Pitts WM, Lee CS, Lewis WA, Fann WE (1983) Multiple-dose doxepin kinetics in depressed patients. Clin Pharmacol Ther 34:509–515
Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Dekker, New York, pp 344–345
Gram LF, Overo KF (1972) Drug interaction: Inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br Med J 1:463–465
Gram LF, Reisby N, Ebsen I, Nagy A, Dencker SJ, Bech P, Petersen GO, Christiansen J (1976a) Plasma levels and antidepressive effect of imipramine. Clin Pharmacol Ther 19:318–324
Gram LF, Andreasen PB, Overo KF, Christiansen J (1976b) Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man. Psychopharmacology 50:21–27
Gram LF, Sondergaard I, Christiansen J, Petersen GO, Reisby N, Ebsen I, Ortmann J, Nagy A, Dencker SJ, Jacobsen O, Krautwald O (1977) Steady-state kinetics of imipramine in patients. Psychopharmacology 54:255–261
Gram LF, Bjerre M, Kragh-Sorensen P, Kvinesdal B, Molin J, Pedersen OL, Reisby N (1983) Imipramine metabolites in blood of patients during therapy and after overdose. Clin Pharmacol Ther 33:335–342
Islam SI, Idle JR, Smith RL (1980) The polymorphic 4-hydroxylation of debrisoquine in a Saudi Arab population. Xenobiotica 10:819–825
Joyce PR, Sharman JR (1985) Doxepin plasma concentrations in clinical practice could there be a pharmacokinetic explanation for low concentrations. Clin Pharmacokinet 10:365–370
Lewis P, Rack PH, Vaddadi KS, Allen JJ (1980) Ethinic differences in drug response. Postgrad Med J [Suppl 1] 56:46–49
Mahy GE (1978) The effect of clomipramine on depression in Barbadian patients. West Indian Med J 27:75–80
Muscettola G, Goodwin FK, Potter WZ, Claeys MM, Markey SP (1978) Imipramine and desipramine in plasma and spinal fluid. Relationship to clinical response and serotonin metabolism. Arch Gen Psychiatry 35:621–625
Nagy A, Johansson R (1975) Plasma levels of imipramine and desipramine in man after different routes of administration. Naunyn-Schmiedeberg's Arch Pharmacol 290:145–160
Preskorn SH, Weller EB, Weller RA, Glotzbach E (1983) Plasma levels of imipramine and adverse effects in children. Am J Psychiatry 140:1332–1335
Potter WZ, Zavadil AP, Kopin IJ, Goodwin FK (1980) Single-dose kinetics predict steady-state concentrations of imipramine and desipramine. Arch Gen Psychiatry 37:314–320
Potter WZ, Calil HM, Sutfin TA, Zavadil AP, Jusko WJ, Rapoport J, Goodwin FK (1982) Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther 31:393–401
Rudorfer MV, Lane EA, Chang WH, Zhang M, Potter WZ (1984) Desipramine pharmacokinetics in Chinese and Caucasian volunteers. Br J Clin Pharmacol 17:433–440
Task Force on the Use of Laboratory Tests in Psychiatry (1985) Tricyclic antidepressent — blood level measurements and clinical outcome: an APA Task Force Report. Am J Psychiatry 142:155–162
Ziegler VE, Biggs JT (1977) Tricyclic plasma levels — effect of age, race, sex, and smoking. JAMA 238:2167–2169
Ziegler VE, Biggs JT, Wylie LT, Rosen SH, Hawf DJ, Coryell WH (1978) Doxepin kinetics. Clin Pharmacol Ther 23:573–579
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Yazigi, A., Chaleby, K. Steady-state kinetics of doxepin and imipramine in Saudi patients with interethnic comparison. Psychopharmacology 95, 63–67 (1988). https://doi.org/10.1007/BF00212768
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00212768